Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nutex Health Inc (NUTX)

Nutex Health Inc (NUTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nutex Health Inc 1776 Yorktown St Suite 700 HOUSTON TX 77056 USA

www.nutexhealth.com Employees: 944 P: 713-660-0557 F: 832-787-1278

Sector:

Medical

Description:

Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON.

Key Statistics

Overview:

Market Capitalization, $K 761,495
Enterprise Value, $K 618,875
Shares Outstanding, K 6,968
Float, K 3,855
% Float 55.32%
Short Interest, K 994
Short Float 14.27%
Days to Cover 5.45
Short Volume Ratio 0.62
% of Insider Shareholders 44.68%
% of Institutional Shareholders 5.32%

Financials:

Annual Sales, $ 875,260 K
Annual Net Income, $ 70,790 K
Last Quarter Sales, $ 151,680 K
Last Quarter Net Income, $ 18,420 K
EBIT, $ 275,630 K
EBITDA, $ 296,160 K

Growth:

1-Year Return -26.66%
3-Year Return 28.22%
5-Year Return -73.98%
5-Year Revenue Growth 54,947.80%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.61 on 03/05/26
Next Earnings Date 05/12/26 [--]
Earnings Per Share ttm 8.98
EPS Growth vs. Prev Qtr -79.25%
EPS Growth vs. Prev Year -85.52%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/03/24

NUTX Ratios

Ratio
Price/Earnings ttm 11.76
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 17.67%
Return-on-Assets % 7.37%
Profit Margin % 8.09%
Debt/Equity 0.10
Price/Sales 0.84
Price/Cash Flow 7.88
Price/Book 1.70
Book Value/Share 59.89
Interest Coverage 12.01
60-Month Beta 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.